查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1358085

糖尿病足溃疡治疗市场：按产品、按溃疡类型、按最终用户、按地区

Diabetic Foot Ulcers Treatment Market, By Product, By Ulcer Type, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 188 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2023 年，全球糖尿病足溃疡治疗市场规模将达到 77.2 亿美元，预测期内（2023-2030 年）年复合成长率为 10.2%。

报告范围 报告详情
基准年 2022年 2023年市场规模 77.2亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 10.20% 2030年市场规模预测 152.1亿美元
糖尿病足溃疡治疗的全球市场占有率(%) （按产品），2023 年
糖尿病足溃疡治疗市场-IMG1

糖尿病足溃疡是糖尿病控制不佳的患者最常见的併发症之一。它通常是由血糖控制不良、潜在的神经病变、末稍血管疾病或足部护理不良所引起。它也是足部骨髓炎和下肢截肢的最常见原因之一。这些溃疡通常发生在经历重复性创伤或压力感的足部区域。该疾病通常是慢性的，跨专业的方法可以产生最好的结果。足病诊疗师、内分泌科医生、初级保健医生、血管外科医生和感染疾病专家的共同参与是极为有益的。这是门诊和住院时常遇到的情况。因此，预计市场上新技术的引入将在预测期内推动全球糖尿病足溃疡治疗市场的成长。

市场动态

医疗产业的主要参与者和研究机构专注于开发用于各种治疗程序的技术进步、药物、设备和系统。因此，在市场上引入此类先进产品预计将在预测期内推动全球糖尿病足溃疡治疗市场的成长。例如，2023年7月27日，贝尔法斯特女王大学的研究人员设计了一种被称为支架的新型3D列印绷带，提出了一种治癒糖尿病足溃疡（DFU）的创新治疗方法。这项新发现将脂质奈米粒子和水凝胶结合起来，创造出个人化的类皮肤 3D 列印支架。该支架结合了大量释放和持续释放含抗生素分子的能力，可治疗糖尿病溃疡。

本研究的主要特点

  • 本报告详细分析了全球糖尿病足溃疡治疗市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率(CAGR)。它揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球糖尿病足溃疡治疗市场的主要企业。
  • 该报告的见解将使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
  • 全球糖尿病足溃疡治疗市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球糖尿病足溃疡治疗市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
  • 影响分析
  • 最近测试启动
  • 流行病学
  • 合併、收购和合作
  • 法规场景
  • 主要进展
  • PEST分析

第4章全球糖尿病足溃疡治疗市场-新型冠状病毒感染疾病（COVID-19）的影响分析

  • 经济影响
  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 对需求和供给的影响

第5章全球糖尿病足溃疡治疗市场，按产品，2018-2030

  • 先进的伤口敷料
  • 皮肤替代
  • 生长因子
  • 负压伤口护理仪
  • 其他的

第6章全球糖尿病足溃疡治疗市场，依溃疡类型，2018-2030

  • 神经病变溃疡
  • 缺血性溃疡
  • 神经缺血性溃疡

第7章全球糖尿病足溃疡治疗市场，依最终用户划分，2018-2030 年

  • 医院
  • 专科诊所
  • 长期照护中心
  • 门诊手术中心

第8章2018-2030年全球糖尿病足溃疡治疗市场（按地区）

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • 公司简介
    • 3M Healthcare
    • Braun Melsungen AG
    • Smith &Nephew, Inc.
    • Organogenesis, Inc.
    • Derma Sciences Inc.
    • Sigvaris Inc.
    • Acelity LP Inc.
    • Osiris
    • Molnlycke Health Care AB
    • Alkem Laboratories Ltd.
    • Healthium Medtech
    • Kerecis
    • Podimetrics
    • Carmell Corporation
    • Paracrine, Inc.
    • VIVEX Biologics, Inc.
    • PolarityTE, Inc.

第10章章

  • 参考
  • 调查方法
简介目录
Product Code: CMI1357

The global diabetic foot ulcers treatment market is estimated to be valued at US$ 7.72 Bn in 2023 and is expected to exhibit a CAGR of 10.2% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 7.72 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 10.20% 2030 Value Projection: US$ 15.21 Bn
Global Diabetic Foot Ulcers Treatment Market Share (%), By Product, 2023
Diabetic Foot Ulcers Treatment Market - IMG1

Diabetic foot ulcers are among the most common complications in patients with diabetes mellitus, which is not well controlled. It is usually the result of poor glycemic control, underlying neuropathy, peripheral vascular disease, or poor foot care. It is also one of the most common causes of osteomyelitis of the foot and amputation of the lower extremities. These ulcers are usually in areas of the foot that encounter repetitive trauma and pressure sensations. The disease is typically chronic, and an interprofessional approach will have the best outcome. The combined involvement of a podiatrist, endocrinologist, primary care physician, vascular surgeon, and infectious disease specialist is extremely beneficial. It is a commonly encountered scenario in both outpatient and inpatients settings. Thus, the introduction of new technology in the market is expected to drive the growth of the global diabetic foot ulcers treatment market over the forecast period.

Market Dynamics

The key players and the research institutes in the medical industry are focusing on the development of technological advancements, drugs and instruments, and systems for various treatment procedures. Thus, the introduction of such advanced products in the market is expected to drive growth of the global diabetic foot ulcers treatment market over the forecast period. For instance, on July 27, 2023, researchers from Queen's University Belfast designed a new 3D-printed bandage known as a scaffold, which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs). The new discovery combines lipid nanoparticles and hydrogels, which are used to create personalized, skin-like 3D-printed scaffolds. These scaffolds have the ability to release both a bulk and sustained release of antibiotic-loaded molecules to treat diabetic ulcers.

Key features of the study:

  • This report provides an in-depth analysis of the global diabetic foot ulcers treatment market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global diabetic foot ulcers treatment market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include 3M Healthcare, Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis, Inc., Derma Sciences Inc., Sigvaris Inc., Acelity L.P. Inc., Osiris, Molnlycke Health Care AB, Alkem Laboratories Ltd., Healthium Medtech, Kerecis, Podimetrics, Carmell Corporation, Paracrine, Inc., VIVEX Biologics, Inc., and PolarityTE, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global diabetic foot ulcers treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetic foot ulcers treatment market.

Detailed Segmentation:

  • By Product:
    • Advance Wound Dressings
    • Skin Substitutes
    • Growth Factors
    • Negative Pressure Wound Therapy Devices
    • Other Devices
  • By Ulcer Type:
    • Neuropathic Ulcers
    • Ischemic Ulcers
    • Neuro-ischemic Ulcers
  • By End User:
    • Hospital
    • Specialty Clinics
    • Long Term Care Centers
    • Ambulatory Surgical Centers
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • 3M Healthcare
    • Braun Melsungen AG
    • Smith & Nephew, Inc.
    • Organogenesis, Inc.
    • Derma Sciences Inc.
    • Sigvaris Inc.
    • Acelity L.P. Inc.
    • Osiris
    • Molnlycke Health Care AB
    • Alkem Laboratories Ltd.
    • Healthium Medtech
    • Kerecis
    • Podimetrics
    • Carmell Corporation
    • Paracrine, Inc.
    • VIVEX Biologics, Inc.
    • PolarityTE, Inc.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Ulcer Type
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Diabetic Foot Ulcers Treatment Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Diabetic Foot Ulcers Treatment Market, By Product, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Advance Wound Dressings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Skin Substitutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Growth Factors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Negative Pressure Wound Therapy Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Other Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

6. Global Diabetic Foot Ulcers Treatment Market, By Ulcer Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Neuropathic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Ischemic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Neuro-ischemic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

7. Global Diabetic Foot Ulcers Treatment Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Long Term Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

8. Global Diabetic Foot Ulcers Treatment Market, By Region, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • 3M Healthcare*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Braun Melsungen AG
    • Smith & Nephew, Inc.
    • Organogenesis, Inc.
    • Derma Sciences Inc.
    • Sigvaris Inc.
    • Acelity L.P. Inc.
    • Osiris
    • Molnlycke Health Care AB
    • Alkem Laboratories Ltd.
    • Healthium Medtech
    • Kerecis
    • Podimetrics
    • Carmell Corporation
    • Paracrine, Inc.
    • VIVEX Biologics, Inc.
    • PolarityTE, Inc.

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact